Guru Ownership Trend
Guru Analysis for Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix, Inc. (OCUL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $52.42 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $26.05 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 90.3%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 67.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Ocular Therapeutix, Inc. (OCUL)
Major holders include Steven Cohen ($32.33 M), Cliff Asness ($9.33 M), Paul Tudor Jones ($5.13 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 5.14 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $26.05 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited OCUL. The total reported sell value was $30.48 M.
Yes, 0 managers opened new positions in OCUL, and 1 increased their existing holdings. The total reported buy value was $4.43 M.